Dr. Soo H. Abboud, MD

Dr. Abboud practices at Good Shepherd Penn Partners - HOPD (3737 Market St, 2nd Fl) in Philadelphia, Pennsylvania.

Dr. Abboud's NPI, 1821033440, was assigned on June 18, 2006. Dr. Abboud graduated from The Johns Hopkins University School of Medicine in 1998. Dr. Abboud holds Pennsylvania license MD073056L.

Dr. Abboud's primary practice is Good Shepherd Penn Partners - HOPD (3737 Market St, 2nd Fl), at 3737 Market St, 2nd Fl, Philadelphia, PA 19104.

Dr. Abboud's primary practice is Good Shepherd Penn Partners - HOPD (3737 Market St, 2nd Fl) in Philadelphia, Pennsylvania. Dr. Abboud is also affiliated with Hospital of the University of Pennsylvania. The medical group on file is Penn Medicine Lancaster General Health. Dmand AI also links Dr. Abboud to 4 more hospitals, 1 breast imaging center and 1 ambulatory surgery center, each named with a free account. Dr. Abboud's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Abboud practices, 8 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Abboud's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Abboud is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dr. Abboud is licensed in Pennsylvania.

Dmand AI lists acute sinusitis, chronic ear infection, chronic nasal allergies, chronic sinusitis, ear eustachian tube disorders, endoscopic sinus surgery, hearing loss and impairment and larynx and vocal cord disease among the conditions Dr. Abboud treats.

CMS data shows 1,179 Medicare services from Dr. Abboud across 6 procedure codes in 2024, for 633 Medicare patients. Medicare paid $62,950 for them.

CMS counts 633 Medicare patients who saw Dr. Abboud in 2024. The largest group is 65 to 74, with 318 patients. 74% of them have high cholesterol, and 64% have high blood pressure. 11% are also on Medicaid. Their average risk score is 1.08, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Abboud's median patient age at 61, with 64% women.

In 2024, Dr. Abboud wrote 1,450 Medicare Part D claims for 514 patients. 88% of them were for generic drugs. CMS names the drug for 1,329 of them, across 18 drugs with 11 or more claims each, at $116,839 in total drug cost. In 2023, CMS named 1,227 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Abboud for performance year 2024, reported as part of a group. Dr. Abboud accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Dr. Abboud in 2013. Dr. Abboud's most frequent co-author is Natasha Mirza, MD.

CMS Open Payments shows 91 general payments to Dr. Abboud from 13 drug and device companies from 2016 to 2025. Royalties and licenses make up the largest share, 76% of the total. Zimmer Biomet Holdings, Inc. paid the most, $74,907.

Dmand AI lists 4 awards for Dr. Abboud, most recently Philadelphia Magazine in 2014.

Dr. Abboud graduated from The Johns Hopkins University School of Medicine in 1998. Dr. Abboud is a member of NHS.

Dr. Abboud is in network with 19 carriers, including Aetna, Blue Cross Blue Shield of Michigan and HCSC. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.